Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 3


Results: 16
    1
    2
    3
    4
    5

    The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1.

    Published in:
    Journal of Viral Hepatitis, 2015, v. 22, n. 3, p. 254, doi. 10.1111/jvh.12289
    By:
    • Oze, T.;
    • Hiramatsu, N.;
    • Yakushijin, T.;
    • Yamada, R.;
    • Harada, N.;
    • Morishita, N.;
    • Oshita, M.;
    • Mita, E.;
    • Ito, T.;
    • Inui, Y.;
    • Inada, M.;
    • Tamura, S.;
    • Yoshihara, H.;
    • Imai, Y.;
    • Kato, M.;
    • Miyagi, T.;
    • Yoshida, Y.;
    • Tatsumi, T.;
    • Kasahara, A.;
    • Hayashi, N.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2015, v. 22, n. 3, p. i, doi. 10.1111/jvh.12320
    Publication type:
    Article
    12
    13
    14
    15
    16